Rapid tests got more sensitive when antibodies were positioned carefully
A two-part design improved detection of several cancer markers and measured two of them at once in serum samples.
Editorial illustration — not from the study.
Researchers redesigned two antibody-binding points in a lateral flow test: fluorescent particles carrying detection antibodies and the strip’s test line, where the target is captured. The design used a chemical linker to orient antibodies on the particles and a biotin–streptavidin system to organize antibodies on the test line.
For two markers, the approach improved the tests’ detection limits by about 14 to 19 times compared with randomly attached antibodies and an unmodified test line. The researchers also adapted the system to detect six cancer-related markers and used differently colored fluorescent particles to measure CYFRA21-1 and CEA simultaneously in 28 clinical serum samples.
How antibody positioning changed results
The best-performing particle design, called P-6, used a para-substituted boronic acid linker to attach antibodies through sugar structures on their Fc regions—the part opposite the antigen-binding end. Combined with a biotin–streptavidin-modified test line, it produced detection limits of 0.0352 nanograms per milliliter for CYFRA21-1 and 0.0808 nanograms per milliliter for CEA. These represented approximately 19-fold and 14-fold improvements, respectively, over the conventional comparison design.
The researchers found that improving only one antibody-binding surface was not enough: the ranking of probe designs changed depending on the chemistry used at the test line. The combined design also reduced nonspecific binding and false-positive signals, according to the study. The approach worked with six markers—CYFRA21-1, CEA, alpha-fetoprotein, carbohydrate antigen 125, carbohydrate antigen 15-3 and prostate-specific antigen—by changing the antibody while keeping the surface chemistry unchanged.
Using fluorescent polymer particles with different colors, the researchers detected CYFRA21-1 and CEA together on one strip with minimal cross-reactivity. Results from 28 clinical serum samples agreed with a hospital reference method to within about 8 percent, as reported in the paper.
Why the design matters
Lateral flow tests are attractive for rapid, point-of-care use, but their sensitivity can be limited when antibodies attach in orientations that make their target-binding regions difficult to access. This work indicates that controlling antibody orientation at both recognition points can improve signal generation more than changing either point alone.
The same design also supported simultaneous measurement of two markers on a single strip and was tested in clinical serum samples. That makes the approach relevant to efforts to increase the information provided by rapid tests, although the reported clinical validation does not by itself establish how the tests would perform across larger or more varied patient groups.
Evidence and caveats
The evidence comes from comparisons among engineered particle and test-line chemistries, measurements using six biomarkers, multiplex testing, and a clinical serum comparison involving 28 samples. The study compared the multiplex results with a hospital reference method and reported agreement of about 8 percent.
The clinical sample set was small, and the provided information does not establish diagnostic sensitivity, specificity or clinical outcomes in a larger patient population. The work demonstrates improved analytical detection and limited clinical validation, rather than a full evaluation of routine clinical use.
Researchers developed a Schirmer strip that simultaneously indicates glucose and pH through color changes, with smartphone image analysis helping assess the results. In tests using artificial tear fluid, the glucose signal appeared within 30 seconds and had a visual detection limit of 0.5 mM.
Researchers have used hydrogen plasma to process Nd-Fe-B magnet machining waste, separating it into metallic iron and a rare-earth oxide-rich fraction. The process also formed rare-earth hydrides, creating feedstocks that could be used in further magnet production without acid.
An article explores how nanomaterials could support water purification as pollution and water scarcity put pressure on clean supplies. It discusses materials that trap toxic metals and membranes designed to filter very small contaminants, while noting their possible uses and limitations.
